Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

SHE:301281 Revenue

Shandong Keyuan Pharmaceutical had revenue of 151.07M CNY in the quarter ending September 30, 2026, with 101.90% growth. This brings the company's total for the last twelve months to 578.07M, up 32.73% year-over-year. In the year 2025, Shandong Keyuan Pharmaceutical had annual revenue of 398.23M, down -14.12%. That makes Shandong Keyuan Pharmaceutical the 23,756th largest company in the world by revenue and 4,283rd in China.

• Revenue (ttm): 578.07M
• Revenue Growth: +32.73%
• P/S Ratio: 7.65
• Revenue / Employee: 889.34K
• Employees: 650
• Market Cap: 4.42B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 194.30M 48.8%
• North China 82.65M 20.8%
• Overseas 43.71M 11.0%
• Southwest 34.22M 8.6%
• Central China 17.92M 4.5%
• Northeast 11.90M 3.0%
• South China 10.15M 2.5%
• Northwest 3.38M 0.8%

Fiscal year ended Dec 31, 2025 See the full SHE:301281 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	398.23M	-65.49M	-14.12%
Dec 31, 2024	463.72M	16.13M	3.60%
Dec 31, 2023	447.58M	4.72M	1.07%
Jan 1, 2023	442.87M	21.98M	5.22%
Jan 1, 2022	420.89M	53.83M	14.67%

Data Source: S&P Global Market Intelligence Last updated: Oct 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error